Tropicamide buccal film - NeuroHealing Pharmaceuticals

Drug Profile

Tropicamide buccal film - NeuroHealing Pharmaceuticals

Alternative Names: Intra-oral slow dissolving muco-adhesive tropicamide thin film; NH-004

Latest Information Update: 18 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NeuroHealing Pharmaceuticals
  • Class Antihyperglycaemics; Eye disorder therapies; Pyridines
  • Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Sialorrhoea

Most Recent Events

  • 01 Dec 2015 NeuroHealing Pharmaceuticals completes a phase II trial for Sialorrhoea in France (NCT01844648)
  • 17 Aug 2015 No recent reports on development identified - Phase-II for Sialorrhoea in Argentina (Buccal)
  • 07 Aug 2015 NeuroHealing Pharmaceuticals completes enrolment in its phase II trial for Sialorrhoea in France (NCT01844648)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top